|
US2021023005A1
|
|
Cannabinoid-containing compositions in the form of spheres or sphere-like particles, methods for their preparation, and therapeutic applications
|
|
MX2015010517A
|
|
Etanercept composition having improved stability.
|
|
MX2012014071A
|
|
Stable pharmaceutical composition for treating osteoporosis.
|
|
MX2012014070A
|
|
Metformin-orlistat compositions.
|
|
MX2012008541A
|
|
New differential-release pharmaceutical composition containing three active principles.
|
|
MX2012002877A
|
|
Pharmaceutical composition of combined therapeutic effect for treating gastritis.
|
|
MX2010009039A
|
|
Chimeric protein with htnf-a affinity.
|
|
US2011039804A1
|
|
Composition of Risedronate and Vitamin D3
|
